For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Chemotherapy Followed by Radiation Treatment | Gemcitabine, Taxotere, Xeloda (GTX)-Stereotactic Radiosurgery (SRS). GTX: 21 day cycle x 2 Gemcitabine 750mg/m2 on days 4 and 11 Taxotere® (docetaxel) 30 mg/m2 on days 4 and 11 Xeloda® (capecitabine) 750 mg/m2 on days 1-14. Stereotactic body radiation therapy (SBRT) 25. | None | None | 0 | 2 | 2 | 2 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTC V3 | View |
| Intermittent hypotension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTC V3 | View |
| Pale skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Itchy rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Hand foot syndrome | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTC V3 | View |
| Dizziness/lightheadedness | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Chest tightness | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTC V3 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTC V3 | View |
| Increased fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Insomia | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Cracks on lips | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Cracks on feet | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Red peeling spots on arms | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTC V3 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Yellow stools | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Hemorrhoid | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Malabsorption | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Mouth sores | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Intermittent nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Taste alteration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTC V3 | View |
| Calf tightness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTC V3 | View |
| Sort throat/redness | SYSTEMATIC_ASSESSMENT | General disorders | CTC V3 | View |
| Voice changes (raspy) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTC V3 | View |